Overview
Sophie Glinton practices practicing medicine in London, United Kingdom.
Ms. Glinton is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Geographic Atrophy, Age-Related Macular Degeneration (ARMD), and Late-Onset Retinal Degeneration.
She is actively involved in clinical research, co-authoring 10 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Sophie L. Glinton
Is Sophie L. Glinton a top-rated expert for Geographic Atrophy?
MediFind is an objective health platform that identifies experts based on real-world data. Sophie L. Glinton is classified as an Advanced expert for Geographic Atrophy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Sophie L. Glinton participate in research or clinical trials?
Yes. Sophie L. Glinton has published 10 articles and abstracts on conditions like Geographic Atrophy. You can view a list of Sophie L. Glinton's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Age-Related Macular Degeneration (ARMD)
- Geographic AtrophyMs. Glinton isAdvanced. Learn about Geographic Atrophy.
- Late-Onset Retinal DegenerationMs. Glinton isAdvanced. Learn about Late-Onset Retinal Degeneration.